0.151
Precedente Chiudi:
$1.25
Aprire:
$1.44
Volume 24 ore:
104.82M
Relative Volume:
31.16
Capitalizzazione di mercato:
$17.52M
Reddito:
$1.93M
Utile/perdita netta:
$-3.10M
Rapporto P/E:
-0.00923
EPS:
-16.3657
Flusso di cassa netto:
$-1.93M
1 W Prestazione:
-91.33%
1M Prestazione:
-88.90%
6M Prestazione:
-91.47%
1 anno Prestazione:
-96.11%
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Confronta SXTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
SXTC
China Sxt Pharmaceuticals Inc
|
0.151 | 145.03M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
China Sxt Pharmaceuticals Inc Borsa (SXTC) Ultime notizie
China SXT Pharmaceuticals announces $10M registered direct offering - TipRanks
China SXT Pharmaceuticals to raise $10 million in share offering By Investing.com - Investing.com India
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering of Class A Ordinary Shares - Quiver Quantitative
Why one investor agreed to buy 66,666,666 shares of this drugmaker - Stock Titan
Promising Chinese Stocks To ResearchJanuary 9th - MarketBeat
On Friday, there are stocks with unusual volume. Let's take a look. - Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
SXTC Stock Soars Amid Strategic AI Initiative Expansion - timothysykes.com
Friday's pre-market session: top gainers and losers - Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
China SXT Pharmaceuticals (SXTC) stock whipsaws after AI “clinics” plan, with Friday open in focus - TechStock²
RELX share price nudges up on buyback update as Feb 12 results near - TechStock²
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga
What dividend safety score for China SXT Pharmaceuticals Inc. stock2025 Winners & Losers & Safe Capital Growth Tips - ulpravda.ru
Why MITT.PRC stock could be next big winnerJuly 2025 Big Picture & Daily Profit Focused Screening - ulpravda.ru
After-Hours Biotech Gainers: RVMD Soars On Merck Deal Talks Reports, SXTC, KALV, SGMT Rally - RTTNews
United States Equities Show Sector Divergence At Close8 Jan - Kalkine Media
Can China SXT Pharmaceuticals Inc. stock maintain growth trajectoryPortfolio Gains Report & Real-Time Market Trend Scan - ulpravda.ru
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - Investing.com UK
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% By Investing.com - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - Investing.com
BC-Most Active Stocks - WFMZ.com
How China SXT Pharmaceuticals Inc. stock reacts to global recession fearsQuarterly Profit Review & Verified Chart Pattern Signals - ulpravda.ru
Why Is Penny Stock China SXT (SXTC) Up Almost 200% Today? - TipRanks
Most active stocks in Thursday's session - Chartmill
Crypto: SXTC's Astonishing Rise: What You Must Know Before It's Too Late - InteractiveCrypto
Dow Theory LettersChina SXT Pharmaceuticals, Inc.Common Stock (Nasdaq:SXTC) Stock Quote - FinancialContent
Crypto: Is SXTC About to Break Out? The Chart Pattern Nobody's Discussing - InteractiveCrypto
Best Chinese Stocks To Watch TodayJanuary 8th - MarketBeat
Roadzen (NASDAQ: RDZN) Strengthens Platform with Strategic VehicleCare Acquisition – Market Signals Point to New Highs Alongside NVVE, JTAI, SXTC, UAVS - FinancialContent
China SXT announces launch of Strategic AI Insights Initiative - TipRanks
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
How rising interest rates impact China SXT Pharmaceuticals Inc. stockJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
China SXT launches AI initiative for TCM product development By Investing.com - Investing.com South Africa
FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT - The Manila Times
China SXT Pharmaceuticals Launches Strategic Artificial Intelligence Insights Initiative to Enhance TCM Product Development and Market Intelligence - Quiver Quantitative
AI-powered TCM clinics: how China SXT is rethinking traditional care - Stock Titan
Chinese Stocks Worth WatchingJanuary 4th - MarketBeat
Technical Analysis: Srestha Finvest Limited (539217)Fibonacci Retracement Levels & Affordable Market Growth - bollywoodhelpline.com
Evolution Metals & Technologies Corp. (EMAT) Stock, Price, News, Quotes, Forecast and Insights - MSN
Promising Chinese Stocks To Add to Your Watchlist – January 6th - Defense World
Promising Chinese Stocks To Add to Your WatchlistJanuary 6th - MarketBeat
Chinese Stocks Worth Watching – January 4th - Defense World
Chinese Stocks To Keep An Eye On – January 3rd - Defense World
Chinese Stocks To Keep An Eye OnJanuary 3rd - MarketBeat
Chinese Stocks To Watch TodayDecember 31st - MarketBeat
Top Chinese Stocks To Watch NowJanuary 2nd - MarketBeat
Macro Trends and Their Impact on Regal Entertainment and Consultants Limited (531033)Mean Reversion Trades & Free Real-Time Trading Signals - bollywoodhelpline.com
What analysts say about China SXT Pharmaceuticals Inc 2RY stockMoving Average Strategies & Access Free Tools and Start Investing - earlytimes.in
Order Book Volume Tilts Bullish on Nidhi Granites LimitedStochastic Oscillator Alerts & Explosive Profit Trading - bollywoodhelpline.com
China Sxt Pharmaceuticals Inc Azioni (SXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):